Fenwick & West represented Phil Inc., an end-to-end technology platform for distributing and managing specialty prescription drugs, in its $25M Series B financing led by new investor GreatPoint Ventures, with support from Tarsadia Investments, Crosslink Capital and Uncork Capital.

The funding will fuel company growth, with a focus on hiring technical talent and expanding geographic footprint. More information about Phil’s $25M Series B financing can be obtained from the company press release.

The Fenwick transaction team was led by corporate lawyers Michael Esquivel, Stefano Quintini, Malcom Katz, Kyle Canchola and Benjamin Toussant.

Login

Don’t have an account yet?

Register